While it is still unclear what caused the fire at the Christiana Hospital in the North West last week, residents are concerned about what this means for their health needs. Millions of rands’ worth of infrastructure upgrades were destroyed by a fire that left a big part of the hospital in ruins. Nthusang Lefafa reports.
Shortages of healthcare workers are contributing to long waiting times at healthcare facilities, poor treatment adherence, and are undermining the response to HIV and tuberculosis (TB) in the Free State, findings in a new report show. Refilwe Mochoari attended the launch of the report and asked the Free State Department of Health for its response.
Already very long waiting times for gender-affirming surgery in South Africa’s public sector have gotten even longer due to the COVID-19 pandemic. Tiyese Jeranji investigates the challenges transgender persons in the country face in accessing gender-affirming care.
Findings of two large phase III clinical trials first presented in 2020 showed a new HIV prevention injection to be highly effective. Yet, experts expect that the injection will only reach clinics in late 2022 or early 2023. If the rhetoric about bringing the urgency of COVID-19 to HIV is to mean anything, these timelines should be made shorter.
The first long COVID study conducted in South Africa found that 82% of patients still had persistent or new symptoms a month after their discharge from hospital. However, much is still unknown about what exactly causes this and how to alleviate the suffering, which is becoming an increasing health burden across the globe. Elsabé Brits surveyed the latest evidence and asked local experts to place it in context.
Globally it is estimated that around one in five to one in ten children and adolescents are affected by mental health disorders. In South Africa, the numbers are highly uncertain, particularly at provincial level, where hardly any data is being gathered. Research suggests that a lack of intersectoral collaboration has resulted in children falling through the cracks – so much so that one expert now says South Africa is completely unable to meet the mental health needs of its children. Tiyese Jeranji investigates.
Little is known about the number of people in South Africa who are living with rare diseases. In fact, there is no recognised definition for rare disease in the country, contributing to inadequate record-keeping and very little data on prevalence, treatment options, and support structures. Laura Owings reports.
Many clinics in Limpopo are operating without the required number of staff needed to deliver quality healthcare services, according to a report from Ritshidze, a community healthcare monitoring project. Activists say these staff shortages contribute to long waiting times for patients and overworked staff – which can ultimately undermine the province’s HIV programme.
The Western Cape Department of Health has identified Khayelitsha and Mitchell’s Plain as the areas with the lowest vaccinations and vaccine registrations in the Cape Town metro. By Monday 30 August, only 22.37% of Mitchell’s Plain’s vaccine-eligible population older than 18 years have registered. In Khayelitsha, this number stood at 12.05%. Siyabonga Kamnqa visited the two areas to find out more.
An antiretroviral injection administered every two months has been shown to be highly effective in preventing people from getting HIV in two large trials. Catherine Tomlinson asks what needs to happen before these injections become available to people in South Africa.
Government can avoid the overwhelming of health services and minimise death in an anticipated fourth COVID-19 wave in November/December by getting 90% of people in South Africa over 35 years old vaccinated before then. Life could then return to normal by Christmas, even with ongoing SARS-CoV-2 circulation, contends vaccinologist Professor Shabir Madhi.
One of the most vibrant areas of HIV research these days is the search for new, more convenient ways to use antiretroviral medicines (ARVs) to prevent HIV infection. Elri Voigt rounds up the HIV pre-exposure prophylaxis (PrEP) research presented at the recent International AIDS Society Conference, including a biodegradable antiretroviral implant.